Domov › Rakovina prostaty › Georgia
Klinické štúdie Rakovina prostaty v štáte Georgia
42 štúdií pre Rakovina prostaty hľadá účastníkov v zariadeniach v štáte Georgia.
Mestá v štáte Georgia
Oficiálny text štúdie (anglicky)
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
- Northside Hospital, Atlanta
- Northside Hospital - Duluth, Duluth
- Northside Hospital - Gwinnett, Lawrenceville
Prebieha náborFáza 3
Vek 18 a viac · Muži · Aktualizované 2. 10. 2026 · NCT06931340Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial
- CTCA at Southeastern Regional Medical Center, Newnan
Prebieha náborFáza 3
Vek 18 a viac · Muži · Aktualizované 2. 10. 2026 · NCT07200830A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
- Emory University, Atlanta
Prebieha náborFáza 1
Vek 18 a viac · Všetky pohlavia · Aktualizované 2. 10. 2026 · NCT06465069Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Northeast Georgia Medical Center Braselton, Braselton
- Atlanta VA Medical Center, Decatur
- Northeast Georgia Medical Center-Gainesville, Gainesville
- a 4 ďalších
Prebieha náborObservačná štúdiaVítaní zdravých dobrovoľníkov
Vek 40 až 75 · Všetky pohlavia · Aktualizované 2. 10. 2026 · NCT05334069Addressing Health Literacy With a Tailored Survivorship Care Plan
- Grady Memorial Hospital, Atlanta
- Emory University Hospital/Winship Cancer Institute, Atlanta
- Atlanta VA Medical Center, Atlanta
Prebieha nábor
Vek 18 a viac · Muži · Aktualizované 30. 9. 2026 · NCT06674863Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
- Emory University Hospital Midtown, Atlanta
- Emory University Hospital/Winship Cancer Institute, Atlanta
Prebieha náborFáza 2
Vek 18 a viac · Všetky pohlavia · Aktualizované 30. 9. 2026 · NCT03866382Impact of Fluciclovine (18F) PET (Positron Emission Tomography) on the Management of Prostate Cancer Following Negative or Equivocal PSMA (Prostate-Specific Membrane Antigen) PET Imaging at the Time of Biochemical Recurrence
- Emory University, Atlanta
Prebieha náborFáza 4
Vek 18 a viac · Muži · Aktualizované 29. 9. 2026 · NCT07569926A Study of JNJ-87189401 Combined With JNJ-78278343 for Advanced Prostate Cancer
- Emory University Winship Cancer Institute, Atlanta
Prebieha náborFáza 1
Vek 18 a viac · Muži · Aktualizované 28. 9. 2026 · NCT06095089Barrigel® PPRT (Post-Prostatectomy Radiation Therapy) Trial
- Augusta University Research Institute, Augusta
Prebieha nábor
Vek 18 a viac · Muži · Aktualizované 28. 9. 2026 · NCT06496256This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
- Tennessee Oncology, PLLC - Dalton, Dalton
- Tennessee Oncology, PLLC - Ringgold, Ringgold
Prebieha náborFáza 3
Vek 18 a viac · Muži · Aktualizované 24. 9. 2026 · NCT07028853A Phase 1 Study of BPX-601 CAR T-Cell Therapy in Adult Participants With Prostate Cancer That Has Returned, is Resistant to Treatment and Has Spread
- Emory Winship Cancer Institute, Atlanta
Prebieha náborFáza 1
Vek 18 a viac · Muži · Aktualizované 24. 9. 2026 · NCT07543055Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
- University Cancer and Blood Center LLC, Athens
- Emory University, Atlanta
Prebieha náborFáza 2/3
Vek 18 až 100 · Muži · Aktualizované 22. 9. 2026 · NCT06780670A Study of LY4257496 in Participants With Cancer (OMNIRAY)
- Emory University School of Medicine - Winship Cancer Institute, Atlanta
Prebieha náborFáza 1
Vek 18 a viac · Všetky pohlavia · Aktualizované 22. 9. 2026 · NCT07114601A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
- City of Hope Atlanta, Newnan
Prebieha náborFáza 3
Vek 18 a viac · Muži · Aktualizované 22. 9. 2026 · NCT07213674Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
- University Cancer and Blood Center LLC, Athens
Prebieha náborFáza 3
Vek 18 až 100 · Muži · Aktualizované 22. 9. 2026 · NCT06855277A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation
- Research Site, Newnan
Prebieha náborFáza 3
Vek 18 a viac · Muži · Aktualizované 18. 9. 2026 · NCT06952803High Dose Testosterone for ATM, CDK12 or CHEK2 Altered Prostate Cancers
- Atlanta VA Medical and Rehab Center, Decatur, GA, Decatur
Prebieha náborFáza 2
Vek 18 a viac · Muži · Aktualizované 17. 9. 2026 · NCT05011383Carboplatin or Olaparib for BRcA Deficient Prostate Cancer
- Atlanta VA Medical and Rehab Center, Decatur, GA, Decatur
Prebieha náborFáza 2
Vek 18 a viac · Muži · Aktualizované 17. 9. 2026 · NCT04038502A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
- Emory University School of Medicine- Grady Campus ( Site 0103), Atlanta
- Winship Cancer Institute, Emory University ( Site 0003), Atlanta
Prebieha náborFáza 3
Vek 18 a viac · Muži · Aktualizované 17. 9. 2026 · NCT06925737Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
- Grady Health System, Atlanta
- Emory Proton Therapy Center, Atlanta
- Emory University Hospital Midtown, Atlanta
- a 3 ďalších
Prebieha náborFáza 3
Vek 18 a viac · Muži · Aktualizované 10. 9. 2026 · NCT05946213Prostate Active Surveillance Study
- Emory University, Atlanta
Prebieha náborObservačná štúdia
Vek 21 a viac · Muži · Aktualizované 2. 9. 2026 · NCT00756665Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma
- Emory University - Winship Cancer Institute, Atlanta
Prebieha náborFáza 1
Vek 18 a viac · Všetky pohlavia · Aktualizované 27. 8. 2026 · NCT06582017Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer
- Emory University, Atlanta
Prebieha náborFáza 1
Vek 18 a viac · Muži · Aktualizované 21. 8. 2026 · NCT04221542A Phase 1b/2a Study of Pocenbrodib as Monotherapy and in Combination With Darolutamide in Participants With mCRPC
- Emory University Hospital, Atlanta
Prebieha náborFáza 1/2
Vek 18 a viac · Muži · Aktualizované 20. 8. 2026 · NCT06785636A Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)
- Winship Cancer Institute, Emory University, Atlanta
Prebieha náborFáza 2
Vek 18 a viac · Muži · Aktualizované 17. 8. 2026 · NCT06842498Study of GVV858 as a Single Agent or in Combination With Endocrine Therapy in Patients With HR+/HER2- Breast Cancer and Other Advanced Solid Tumors
- Emory University, Atlanta
Prebieha náborFáza 1/2
Vek 18 a viac · Všetky pohlavia · Aktualizované 30. 7. 2026 · NCT07288359Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
- Grady Health System, Atlanta
- Emory University Hospital Midtown, Atlanta
- Emory University Hospital/Winship Cancer Institute, Atlanta
- a 4 ďalších
Prebieha náborFáza 3
Vek 18 a viac · Muži · Aktualizované 14. 7. 2026 · NCT06592924An Investigational Scan (18F-rhPSMA-7.3 PET-mpMRI) for Targeted Prostate Biopsy Using TRUS-MR Fusion Technique
- Emory University Hospital, Atlanta
Prebieha náborFáza 2
Vek 18 a viac · Muži · Aktualizované 14. 7. 2026 · NCT06865768Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer
- University Cancer and Blood Center LLC, Athens
Prebieha náborFáza 4
Vek 18 až 100 · Muži · Aktualizované 4. 6. 2026 · NCT05803941International Registry for Men With Advanced Prostate Cancer (IRONMAN)
- Morehouse School of Medicine, Atlanta
- Emory Winship Cancer Institute, Atlanta
Prebieha náborObservačná štúdia
Vek 21 a viac · Muži · Aktualizované 22. 5. 2026 · NCT03151629Anti-tumour Activity of (177Lu) rhPSMA-10.1 Injection
- Emory University Hospital, Atlanta
Prebieha náborFáza 1/2
Vek 18 a viac · Muži · Aktualizované 14. 5. 2026 · NCT05413850Using a mHealth App to Improve Quality-of-Life Outcomes in Black Prostate Cancer Survivors
- Georgia College & State University, Milledgeville
Prebieha nábor
Vek 18 a viac · Muži · Aktualizované 1. 4. 2026 · NCT06651359T-reg Function Changes: a Novel Immune Regulatory Effect Underlying Benefit of Statin Use on Lethal Prostate Cancer
- Emory University, Atlanta
Prebieha náborFáza 2
Vek 18 a viac · Muži · Aktualizované 4. 3. 2026 · NCT05586360REVELUTION-2: Relugolix+Abiraterone Acetate (AA) Versus Leuprolide+AA Cardiac Trial
- Emory Proton Therapy Center, Atlanta
- Winship at Emory Midtown, Atlanta
- Emory University Hospital/Winship Cancer Institute, Atlanta
- a 1 ďalších
Prebieha náborFáza 3
Vek 18 a viac · Muži · Aktualizované 24. 2. 2026 · NCT06650579Study of AZD0754 in Participants With Metastatic Prostate Cancer
- Research Site, Atlanta
Prebieha náborFáza 1/2
Vek 18 až 130 · Muži · Aktualizované 23. 2. 2026 · NCT06267729Proton Radiation Therapy for the Treatment of Patients With High Risk Prostate Cancer
- Emory University Hospital/Winship Cancer Institute, Atlanta
Prebieha nábor
Vek 18 a viac · Muži · Aktualizované 17. 2. 2026 · NCT04725903Improving Health Literacy in African-American Prostate Cancer Patients
- Atlanta VA Medical Center, Atlanta
- Grady Memorial Hospital, Atlanta
- Emory University, Atlanta
- a 1 ďalších
Prebieha nábor
Vek 25 až 100 · Muži · Aktualizované 29. 1. 2026 · NCT03322891cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
- North Georgia Health System, Gainesville
Prebieha náborObservačná štúdiaVítaní zdravých dobrovoľníkov
Vek 40 a viac · Všetky pohlavia · Aktualizované 20. 1. 2026 · NCT05366881Evaluation of a Targeted Magnetic Resonance Imaging Contrast Agent in Prostate Cancer Patients
- Emory University, Atlanta
Prebieha náborFáza 1/2
Vek 18 až 90 · Muži · Aktualizované 19. 12. 2025 · NCT06262139A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
- Research Site 114, Atlanta
- Research Site 139, Atlanta
Prebieha náborFáza 1/2
Vek 18 a viac · Všetky pohlavia · Aktualizované 21. 11. 2025 · NCT05914116Z ClinicalTrials.gov, dáta načítané 5. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.